| Autor: |
Heeringa M; Stichting Registratie Evaluatie Bijwerkingen (LAREB), Hertogenbosch., Kuster JA, Meyboom RH, Bouvy M |
| Jazyk: |
Dutch; Flemish |
| Zdroj: |
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 1998 Nov 07; Vol. 142 (45), pp. 2477-80. |
| Abstrakt: |
In 1996 and 1997 the Dutch Pharmacovigilance Foundation LAREB received 6 reports of patients with convulsions that were attributed to prophylactic use of mefloquine. Five patients had no neurological history; one patient had a history of epilepsy but had not had any convulsion during the preceding 5-year period. The convulsions took place 1 to 23 days after start of the treatment with mefloquine. Because of the convulsions, the treatment was discontinued. The 4 patients with known follow-up showed full recovery with regard to the convulsions. The practising physician should be aware of the possible occurrence of rare neuropsychiatric adverse events like convulsions during the prophylactic use of mefloquine. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
